Competing Interests
A competing interest is anything that interferes with, or could be perceived as interfering with, the full and objective presentation, peer review, editorial decision making, or publishing of an article. A detailed definition can be found at PLOS and ICMJE. Any potential competing interests are required to be declared at Bio-protocol (by authors, editors, and reviewers)
Because each published protocol should objectively document how the experiments have been performed, including the sources of reagents and equipment, we specifically request that competing interests also consider the choice of reagents and equipment.
What to declare
Competing interests can be either financial competing interests or non-financial competing interests, which are described in detail at PLOS. At Bio-protocol, one typical type of financial competing interest is the receipt of funding or free products from the vendors of the reagents/equipment or other advertisers.
How to declare
Any potential competing interests are required to be disclosed in the “Competing interests” section designed for authors or editors or reviewers. In addition, there should be a clear indication in "Materials and Methods," "Software," or "Equipment" sections whenever the said reagents/equipment were funded or donated by the associated vendors.
Who should declare
Authors: At the initial submission, authors are responsible for disclosing all financial or non- financial competing interests that might be perceived to bias their work. Bio-protocol will adopt ICMJE guideline and require authors to complete a "Disclosure of Conflicts of Interest" form during the initial submission step.

Editors and reviewers: Editors and reviewers (paid or unpaid) must declare their own competing interests. Bio-protocol follows the guidance of the World Association of Medical Editors and the Council of Science Editors regarding editorial independence. The Editor-in-Chief and associate editors (or guest editors) at Bio-protocol have sole responsibility and accountability for the editorial content of the journal. Bio-protocol editors are completely shielded from the Bio-thing business. Editorial decisions are made solely based on academic merit.

Executive staff who are involved in the editorial process must recuse themselves from any decisions in which a conflict of interest exists. They must not influence any decision-making process on the selection or publishing of a given protocol.

The funders and sponsors of Bio-protocol as well as Bio-thing do not play any role in the selection, reviewing, or publishing of content. There is absolutely no influence of the advertisers on what protocols are selected/published and never will be.

Readers: Anyone who comments on published bio-protocols is required to declare all potential competing interests (financial or non-financial) at the time of posting the comment.

If an undisclosed competing interest comes to light after publication, Bio-protocol will take action as recommended in the COPE guidelines.
We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.